Clinical Trials

Medtronic, Inc.has announced the initiation of a feasibility study of an interventional treatment for erectile dysfunction that uses a specially-designed drug-eluting stent system.

Boston Scientific Corporation has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures.

ValveXchange, Inc. has performed successful First In Man (FIM) surgeries demonstrating the practicality and advantages of its novel Vitality™ two-part heart valve system.

Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS® EXPRESS® Stents and Bypass Surgery.

Cardiola AG announced today that it has placed its patented m.pulse® system in 10 hospitals located in Germany and Switzerland, on the heels of the system’s CE-Mark approval.

Prospera Technologies announces groundbreaking research regarding Negative Pressure Wound Therapy at the 5th Joint Meeting of the European Tissue Repair Society and The Wound Healing Society.

Lutonix, Inc., a privately held medical device start-up, announced that patient enrollment is underway for its three simultaneous first-in-human clinical trials.

Atrium Medical Corporation is proud to announce the release of the interim results of the “COCTAIL Study.”

Edwards Lifesciences Corporation announced that new research demonstrates that using its minimally invasive PORT ACCESS System in mitral valve surgery significantly improves outcomes when compared to conventional sternotomy.

Today, Medtronic, Inc. announces two significant clinical trials related to medical device interventions for stroke.

Acclarent, Inc. today announced the completion of a study evaluating the treatment of patients with Balloon Sinuplasty™ technology in the office setting.

Data presented today at the EUROPACE 2009 congress on the XPECT clinical trial, sponsored by Medtronic, Inc., shows positive results for the Medtronic Reveal® XT Insertable Cardiac Monitor (ICM).

St. Jude Medical, Inc. commends the efforts of investigators in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).

Today, Medtronic, Inc. announces two significant clinical trials related to medical device interventions for stroke.

Norian Corporation, Synthes, Inc. and four top Synthes executives have been indicted and face charges for their alleged involvement in conducting clinical trials of a medical device without the authorization of the US Food and Drug Administration.

Abbott today announced the initiation of SPIRIT PRIME, a clinical trial to study the performance of the company’s next-generation XIENCE PRIME™ Everolimus Eluting Coronary Stent System.